Manasi Patil

Proficient researcher in stem cell biology with a substantial background in mammalian stem cell culture and a strong molecular biology skill set. Proven capacity to work independently and collaborate with the team to meet project terms.

• 7-day industrial training (Packaging of vaccine, production of DPT vaccine, etc.), Serum Institute Pvt. Ltd., Pune, India, 05/2011
• Attended 5-day workshop at the Institute Of Excellence, Mysore on handling of sophisticated instruments (LC-MS, NMR, XRD, SEM), 03/2016

• Research article, Manasi Patil, Naisarg Gamit, Arun Dharmarajan, Gautam Sethi 5, and Sudha Warrier, 02/02/2023, Bioengineering, MDPI, Identification of a Novel Wnt Antagonist Based Therapeutic and Diagnostic Target for Alzheimer’s Disease Using a Stem Cell-Derived Model
• Research article, Naisarg Gamit, Manasi Patil, Soumya B Sundrappa, S. Mohana Sundaram, Gautam Sethi, Arun Dharmarajan, Sudha Warrier, 08/11/2023, Drug Development Research, Mesenchymal stem cell-derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs
• Review, Sudha Warrier, Manasi Patil , Sanyukta Bhansali , Lavanya Varier, Gautam Sethi, 01/2021, Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, Designing precision medicine panels for drug-refractory cancers targeting cancer stemness traits
• Research article, Gurubharathi Bhuvanalakshmi, Naisarg Gamit, Manasi Patil, Frank Arfuso, Gautam Sethi, Arun Dharmarajan, Alan Prem Kumar, and Sudha Warrier, 12/2018, Cancers (Basel), Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma

• Presented a poster and oral presentation on ‘Human Mesenchymal stem cell derived model of Alzheimer's Disease – Effect of Wnt antagonism in neurodegeneration’, 3rd International Conference on INNOVATIONS IN CANCER RESEARCH AND REGENERATIVE MEDICINE (CRRM 2017), Ho Chi Minh city, Vietnam
• Presented on 'Understanding Covid-19 associated neurological effects and increased risk of Alzheimer’s Disease', Interdisciplinary Conference on Healthcare and Technical Research (ICHTR 2021)
• Modulating Wnt signaling pathway to combat Alzheimer’s disease pathogenesis, Interdisciplinary Conference on Healthcare and Technical Research (ICHTR 2022)